• event-free survival - 引用次数：6

  During the median follow up of 36 months,consolidation and maintenance mortalities were 2 and 3 patients,respectively.3-year overall survival(OS) and event-free survival(EFS) rates were 71.5% and 61.0% while the 3-year EFS rate of 58 patients in CR was 78.9%.

  患者预期3年总生存率为71.5%,3年无事件生存率为61.0%,获得CR患者3年无事件生存率为78.9%。

  参考来源 - 全反式维甲酸联合高三尖杉酯碱治疗急性早幼粒细胞白血病的临床研究

·2,447,543篇论文数据，部分数据来源于NoteExpress